Original Source(s)
METIS HU: A New Surgical Perspective
June 3, 2026
Related Content
This Week’s Biopharma News: New Approvals, Appeals, and AI
Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic
June 2, 2026
-
5 min
FDA Monthly Preview: Key June Decisions to Watch
Several FDA decisions across multiple specialties are expected this month.
May 29, 2026
-
3 min
A Topical Route to Neuroprotection?
Topical peptide therapy targets excitotoxicity in retinal degeneration
May 22, 2026
-
3 min